Story · Medicine & Biotech

Alzheon launches second Phase 3 trial for Alzheimer’s drug

1 outlet · first reported by Longevity.Technology 12h ago

Coverage, in order

  1. 12h ago
    Longevity.Technology UK indie study randomized trial
    Alzheon launches second Phase 3 trial for Alzheimer’s drug

    Alzheon has launched ORION-E4, a second Phase 3 trial of oral valiltramiprosate/ALZ-801 designed to confirm benefits seen in the APOLLOE4 mild cognitive impairment subgroup.

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.